In vitro activity of meropenem-ANT3310 and comparators against carbapenem resistant Acinetobacter clinical isolates: implications for low and middle-income countries (LMIC) Navegación de entradas Ceftibuten-avibactam as an oral alternative toceftazidime-avibactam for serine carbapenemase-producing Enterobacterales Meropenem-ANT3310: a novel agent targeting serine carbapenemase-producing Enterobacterales